Mon, December 2, 2024

[ Mon, Dec 02nd 2024 ]: Thomas Matters

RBC's strategy team reveals their top 30 Canadian stock picks for 2025

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Best Energy Stocks for December 2024

[ Mon, Dec 02nd 2024 ]: Thomas Matters

3 Incredible Growth Stocks to Buy Right Now

[ Mon, Dec 02nd 2024 ]: Thomas Matters

3 No-Brainer Warren Buffett Dividend Stocks to Buy in December

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Stock index futures inch lower as investors brace for ton of economic releases in the week

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Stock market today: World shares are mixed as Chi .. ese stocks get a boost from strong factory orders

[ Mon, Dec 02nd 2024 ]: Thomas Matters

3 No-Brainer Stocks to Buy in December

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Best Health Care Stocks for December 2024

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Louisiana-Pacific: Superb Execution, But Not Worth This Much

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Explained: Why FPIs are buying via IPO route and selling in stock market

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Markets Brief: Consumer Stocks Rally, Now Some Look Pricey

[ Mon, Dec 02nd 2024 ]: Thomas Matters

After an 18% jump on its 2024 results, is it too .. r me to consider buying this FTSE 100 hidden gem?

[ Mon, Dec 02nd 2024 ]: Thomas Matters

These five 'hold-forever' stocks offer high returns on equity and capital employed

[ Mon, Dec 02nd 2024 ]: Thomas Matters

'Lame duck' Biden pushing major US policies before Trump's return

[ Mon, Dec 02nd 2024 ]: Thomas Matters

This tech giant has returned 228,500pc over its life and isn't about to stop

[ Mon, Dec 02nd 2024 ]: Thomas Matters

2 FTSE 100 and FTSE 250 value stocks to consider in December!

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Why did the Zip share price smash the market again in November?

[ Mon, Dec 02nd 2024 ]: Thomas Matters

Indian Capital Goods Stocks Regain Investor Favor
Sun, December 1, 2024

[ Sun, Dec 01st 2024 ]: Thomas Matters

Warren Buffett Just Sent Out a Deafening Warning .. gnal to the Market. 3 Things Investors Should Do.

[ Sun, Dec 01st 2024 ]: Thomas Matters

Got a $75,000 Salary? Here's How Much You Should .. Contributing to Your Retirement Savings Each Year

[ Sun, Dec 01st 2024 ]: Thomas Matters

Stock Picking Success: Batting Average Or Slugging Percentage?

[ Sun, Dec 01st 2024 ]: Thomas Matters

I'm About to Retire. Is It Time to Sell My Stocks?

[ Sun, Dec 01st 2024 ]: Thomas Matters

Top Wall Street analysts pick 3 stocks for their attractive prospects

[ Sun, Dec 01st 2024 ]: Thomas Matters

3 Top Energy Stocks to Buy as 2024 Draws to a Close

[ Sun, Dec 01st 2024 ]: Thomas Matters

Warren Buffett Is Holding On To Cash - Should You?

[ Sun, Dec 01st 2024 ]: Thomas Matters

2 no-brainer Warren Buffett stocks to buy into 2025

[ Sun, Dec 01st 2024 ]: Thomas Matters

This AI penny stock could be set to explode higher in 2025

[ Sun, Dec 01st 2024 ]: Thomas Matters

A Bull Market Is Here: 2 Smart Stocks Down 16% and 65% to Buy Right Now

[ Sun, Dec 01st 2024 ]: Thomas Matters

These 3 Dividend-Focused Vanguard ETFs Are Up 14% to 31% in 2024. Here's the Best One to Buy Now.

[ Sun, Dec 01st 2024 ]: Thomas Matters

As Indexes Soar, Does Warren Buffett Know Somethi .. ade a Move That Could Be a Warning for Investors.

[ Sun, Dec 01st 2024 ]: Thomas Matters

The Stock Market Is Doing Something It's Never Do .. "Playing With Fire," According to Warren Buffett

[ Sun, Dec 01st 2024 ]: Thomas Matters

Better Artificial Intelligence Stock: SoundHound vs. Palantir

[ Sun, Dec 01st 2024 ]: Thomas Matters

Dow jumps nearly 200 points to record in short se .. n, S&P 500 posts best month of 2024: Live updates

[ Sun, Dec 01st 2024 ]: Thomas Matters

Ramstad: Readers praise idea for insurance-free doctor's offices in Minnesota

[ Sun, Dec 01st 2024 ]: Thomas Matters

Stocking Up for Christmas?
Sat, November 30, 2024

[ Sat, Nov 30th 2024 ]: Thomas Matters

Mutual fund SIP investments can hit Rs 1 trillion mark by 2030. Here's why

[ Sat, Nov 30th 2024 ]: Thomas Matters

Will Palantir Technologies' Move to the Nasdaq Help the Stock Climb Even Higher?

[ Sat, Nov 30th 2024 ]: Thomas Matters

Australia's Future Fund invests in the global arms industry. Are the returns worth it?

[ Sat, Nov 30th 2024 ]: Thomas Matters

Could Buying Ford Stock Today Set You Up for Life?

[ Sat, Nov 30th 2024 ]: Thomas Matters

The S&P 500 Is Poised to Do Something That's Only .. ld Signal a Big Move for the Stock Market in 2025

[ Sat, Nov 30th 2024 ]: Thomas Matters

How investors can make hay if Trump starts a trade tariff war

[ Sat, Nov 30th 2024 ]: Thomas Matters

$1,000 to invest? DroneShield and this top Australian stock could rise 50% to 80%

[ Sat, Nov 30th 2024 ]: Thomas Matters

If you have over $100k saved and you're afraid to .. Suze Orman says this is the best thing you can do

[ Sat, Nov 30th 2024 ]: Thomas Matters

74% of this FTSE fund is in Nvidia and these 3 top AI stocks!

[ Sat, Nov 30th 2024 ]: Thomas Matters

After a Breakout 2024, Where Will Palantir Stock Be in 1 Year?

[ Sat, Nov 30th 2024 ]: Thomas Matters

S&P 500 and Dow notch gains, capping Wall Street's best month of 2024

[ Sat, Nov 30th 2024 ]: Thomas Matters

Palantir Stock vs. Nvidia Stock: Billionaires Buy One and Sell the Other

[ Sat, Nov 30th 2024 ]: Thomas Matters

The S&P 500 Is on Track to Do Something It Hasn't .. ince 1999, and Here's What It Could Mean for 2025

Why this ASX healthcare share is soaring 26% on study findings

This share is getting a lot of attention on Monday. What's happening? The post Why this ASX healthcare share is soaring 26% on study findings appeared first on The Motley Fool Australia.
The article from MSN discusses the significant surge in the share price of Telix Pharmaceuticals (ASX: TLX), an Australian healthcare company, following the release of promising study results. Telix announced that its investigational prostate cancer imaging agent, TLX591, showed positive outcomes in a Phase I study, demonstrating both safety and efficacy. This news led to a 26% increase in Telix's share price. The study involved patients with metastatic castrate-resistant prostate cancer (mCRPC), and the results indicated that TLX591 could potentially improve the visualization of cancer cells, aiding in more precise treatment. The positive data has not only boosted investor confidence but also highlighted Telix's potential in the global fight against cancer, particularly in the niche of radiopharmaceuticals.

Read the Full MSN Article at:
[ https://www.msn.com/en-au/lifestyle/misc/why-this-asx-healthcare-share-is-soaring-26-on-study-findings/ar-AA1v5cG1 ]